Blood Thinner Dose Check for Older Adults With AFib
Part of Heart & circulation clinical trials.
This study looks at whether older adults with atrial fibrillation are taking the right dose of their blood thinner medicine. It aims to improve how doctors prescribe these medications in primary care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years old or older.
- You have been diagnosed with atrial fibrillation (an irregular heartbeat).
- You have taken a blood thinner (like apixaban, rivaroxaban, or warfarin) sometime in the past year.
- You do not have a mechanical heart valve or severe mitral stenosis (a heart valve problem).
- You are not currently taking part in another drug study that affects blood thinning.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a lower dose of the blood thinner edoxaban can safely prevent another stroke in people aged 80 or older who have atrial fibrillation (an irregular heartbeat) and have already had a stroke or mini-stroke. It may be an option for those at higher risk of bleeding.
This trial tests if talking with a pharmacist helps people with atrial fibrillation remember to take their blood thinner medicine correctly. It may improve stroke prevention.
This study tests a new blood thinner to prevent strokes and blood clots in people with atrial fibrillation (a common heart rhythm problem). You may qualify if you have atrial fibrillation and at least one risk factor for stroke, or if you've never taken a blood thinner before.
This study tests the safety of a new blood thinner for people with atrial fibrillation (AFib) who need long-term stroke prevention. If you qualify, the study will compare this medication to standard anticoagulation therapy.
This study is testing a new scoring system to predict stroke risk in people with atrial fibrillation who are taking DOAC blood thinners. The goal is to help doctors personalize treatment and prevent blood clots.
This trial tests whether switching to a different type of blood thinner is better than continuing the same type after a stroke. It aims to find the safest way to prevent another stroke in people with atrial fibrillation.
Hear when a new Medication Adherence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.